Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols

Author： Costello R.T.   Fauriat C.   Rey J.   Gastaut J.-A.   Olive D.  

Publisher： Elsevier

ISSN： 1470-2045

Source： Lancet Oncology, Vol.5, Iss.1, 2004-01, pp. : 47-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

By Baxevanis Constantin   Sotiropoulou Panagiota   Sotiriadou Nectaria   Papamichail Michael  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 166-175

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis

By Agarwala Sanjiv   Hellstrand Kristoffer   Gehlsen Kurt   Naredi Peter  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 840-841

Springer Publishing Company

Access to resources Recommend Favorite

Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

By Chandramohan Vidyalakshmi   Mitchell Duane A   Johnson Laura A   Sampson John H   Bigner Darell D  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 977-990

Future Medicine

Access to resources Recommend Favorite

Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 6, 2010-07 ,pp. : 462-470

Bentham Science Publishers

Access to resources Recommend Favorite